In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.
The antimicrobial activities of tigecycline (GAR-936) were compared with those of other agents against 1,087 strains recently isolated in 12 Spanish medical centers. Tigecycline showed activity against a wide spectrum of aerobic and anaerobic bacteria, including strains such as methicillin-resistant Staphylococcus aureus, coagulase-negative staphylococci, penicillin-resistant Streptococcus pneumoniae, Enterococcus faecium, Acinetobacter baumannii, and Stenotrophomonas maltophilia.
Betriu
Carmen
C
Department of Clinical Microbiology, Hospital Clínico San Carlos, Spain. cbetriu@efd.net
Rodríguez-Avial
Iciar
I
Sánchez
Blas Ali
BA
Gómez
María
M
Alvarez
Juan
J
Picazo
Juan J
JJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001421:Bacteria, Anaerobic / Q000187:drug effects; D001424:Bacterial Infections / Q000382:microbiology*; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology*; D010403:Penicillin Resistance; D013030:Spain; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline